Related Experiment Video

Updated: Aug 14, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
09:09

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Published on: August 9, 2013

Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle

Gualberto Ruaño1, Paul D Thompson, Andreas Windemuth

  • 1Genomas, Inc., 67 Jefferson St., Hartford, CT 06106, USA. g.ruano@genomas.net

Pharmacogenomics
|November 22, 2005
PubMed

Insights

Genetic variations in vascular function genes, like AGTR1 and NOS3, are linked to statin-induced muscle damage. This research identifies potential biomarkers for predicting statin muscle toxicity in patients.

Area of Science:

  • Pharmacogenomics
  • Cardiovascular Medicine
  • Skeletal Muscle Physiology

Background:

  • Statins are crucial for reducing coronary heart disease risk.
  • Skeletal muscle complaints, from myalgia to rhabdomyolysis, are common statin side effects.
  • Understanding genetic factors influencing statin muscle toxicity is vital for patient safety.

Purpose of the Study:

  • To investigate physiological factors, specifically genetic variations, associated with statin-induced muscle toxicity.
  • To identify genetic associations with serum creatine kinase (CK) levels in patients undergoing statin therapy.

Main Methods:

  • Screened 19 single nucleotide polymorphisms (SNPs) from ten candidate genes involved in vascular homeostasis.
  • Analyzed 102 hypercholesterolemia patients receiving statin therapy.
  • Employed multiple linear regression to assess SNP associations with serum CK levels.

Main Results:

  • Significant associations were found between serum CK activity and SNPs in the angiotensin II Type 1 receptor (AGTR1) gene.
  • Significant associations were also identified with SNPs in the nitric oxide synthase 3 (NOS3) gene.
  • Variability in vascular function genes correlates with CK activity during statin treatment.

Conclusions:

  • Genetic variations in AGTR1 and NOS3 are strongly associated with creatine kinase activity in patients on statins.
  • These findings suggest that vascular smooth muscle function may play a role in statin-induced muscle side effects.
  • Identified genetic markers could potentially predict or explain statin muscle toxicity.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...